Transcription My name is Nancy Hamilton. Right now, I am the training manager at EURORDIS, which is the European Organisation for Rare Diseases. I organise what we call...
Transcription My name is Pauline Kitchiner, and I work at GSK’s Clinical Unit in Cambridge. Which is a purpose built clinical unit to conduct phase one or phase...
Transcription My name is Tamás Bereczky, I come from Budapest, Hungary. I have been working with EUPATI as a patient representative or the representative of a patient organisation,...
Introduction A case report on Phase II patient involvement into Proof of Concept study design, to improve probability of success generating patient-relevant data and meeting current regulatory needs. Where...
Today you will see our patient involvement report on successful patient involvement, make sure you have a read. In the coming weeks we shall share patient involvement reports on trials and...
Published and available for citation: Warner K, See W, Haerry D, Klingmann I, Hunter A and May M (2018) EUPATI Guidance for Patient Involvement in Medicines Research and Development...
Diagnosed with MS and then …. When I got my diagnosis in 2005, I didn’t know a lot about multiple sclerosis. I was absolutely uninformed. Why should we think...
Introduction An example of patient’s own experience of being used as an interface between sponsors and participants of clinical trials. Taking place both in rare diseases with EURORDIS and...
Introduction Novartis Advisory Board meets with six National Psoriasis Patient Organisations to address patient relevant endpoints in psoriasis clinical trials. Where in the process? – Phase III When does...
Introduction A collaboration of Genzyme, International Pompe Association (IPA); UK, Dutch, and US Pompe patient organisations, Erasmus Medical Center and Duke University to establish appropriate measures to ensure the...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
